The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01427101
Verified August 2011 by Uppsala University. Recruitment status was: Active, not recruiting
mortality is messured during the first 90 postoperative days and morbidity during hospital stay.
Patients treated from 1993 are included and during these years treatment strategy has changed. The different strategies are compared but its juts one cohort of patients. No completion date are set due to that reports from other centres show that there are longtime survivers in both treatment groups.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
20 Years to 80 Years (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Patients with Pseudomyxoma Peritonei, sceduled for surgical treatment at Uppsala University Hospital.
Patients with radiology histopathology finding of Pseudomyxoma Peritonei
Preformance status WHO >2 and histopathology shows other origin then Pseudomyxoma Peritonei